Changes in the proteomic profile of adipose tissue-derived mesenchymal stem cells during passages

Background: Human mesenchymal stem cells (hMSC) have recently raised the attention because of their therapeutic potential in the novel context of regenerative medicine. However, the safety of these new and promising cellular products should be carefully defined before they can be used in the clinical setting, as. The protein expression profile of these cells might reveal potential hazards associated with senescence and tumoral transformation which may occur during culture. Proteomic is a valuable tool for hMSC characterization and identification of possible changes during expansion.Results: We used Surface Enhanced Laser Desorption/Ionization-Time Of Flight-Mass Spectrometry (SELDI-ToF-MS) to evaluate the presence of stable molecular markers in adipose tissue-derived mesenchymal stem cells (AD-MSC) produced under conditions of good manufacturing practices (GMP). Proteomic patterns of cells prepared were consistent, with 4 up-regulated peaks (mass-to-charge ratio (m/z) 8950, 10087, 10345, and 13058) through subculture steps (P0-P7) with similar trend in three donors. Among the differentially expressed proteins found in the cytoplasmic and nuclear fractions, a cytoplasmic 10.1 kDa protein was upregulated during culture passages and was identified as S100A6 (Calcyclin).Conclusions: This study suggests for the first time that common variation could occur in AD-MSC from different donors, with the identification of S100A6, a protein prevalently related to cell proliferation and cell culture condition. These results support the hypothesis of common proteomic changes during MSCs expansion and could give important insight in the knowledge of molecular mechanisms intervening during MSC expansion

ANÁLISE DOS EFEITOS HEMODINÂMICOS DURANTE NEFRECTOMIAS: EFEITOS DA ANESTESIA GERAL E INTERVENÇÕES INTRAOPERATÓRIAS

Nephrectomy, the surgical removal of one or both kidneys, is a complex procedure that requires strict control of hemodynamic parameters to ensure the safety and success of the surgery. Therefore, adequate management of anesthesia is crucial to maintain bodily stability, minimizing the risk of intraoperative complications and improving postoperative results. Therefore, anesthetic strategies and intraoperative interventions to optimize hemodynamic control during nephrectomies are extremely important for the best and safest personalized approach for each patient. Objective: To investigate the hemodynamic effects during nephrectomies, with an emphasis on anesthetic management and intraoperative interventions necessary to maintain cardiovascular stability. Methodology: The Cochrane, Scielo and Pubmed databases were used, searching for articles published between 2021 and 2024, in Portuguese or English. Final Considerations: Success in maintaining hemodynamic homeostasis is closely linked to the experience of the surgical and anesthetic team, as well as the implementation of personalized strategies that consider individual clinical conditions. Therefore, effective interventions can significantly reduce the risk of complications and improve postoperative outcomes, emphasizing the importance of an integrated, patient-centered approach to complex procedures such as nephrectomy.A nefrectomia, a remoção cirúrgica de um ou ambos os rins, é um procedimento complexo que exige um controle rigoroso dos parâmetros hemodinâmicos para garantir a segurança e o sucesso da cirurgia. Dessa forma, o manejo adequado da anestesia é crucial para manter a estabilidade corpórea, minimizando o risco de complicações intraoperatórias e melhorando os resultados pós-operatórios. Assim, estratégias anestésicas e intervenções intraoperatórias para otimizar o controle hemodinâmico durante as nefrectomias, são de extrema importância para a melhor e mais segura abordagem personalizada para cada paciente. Objetivo: Investigar os efeitos hemodinâmicos durante nefrectomias, com ênfase no manejo anestésico e nas intervenções intraoperatórias necessárias para manter a estabilidade cardiovascular. Metodologia:  Foram utilizadas as bases de dados Cochrane, Scielo e Pubmed, buscando artigos publicados entre os anos de 2021 e 2024, nos idiomas Português ou Inglês. Considerações Finais: O sucesso na manutenção da homeostase hemodinâmica está intimamente ligado à experiência da equipe cirúrgica e anestésica, bem como à implementação de estratégias personalizadas que considerem as condições clínicas individuais. Portanto, intervenções eficazes podem reduzir significativamente o risco de complicações e melhorar os resultados pós-operatórios, enfatizando a importância de uma abordagem integrada e centrada no paciente para procedimentos complexos como a nefrectomia

Defining the identity of human adipose-derived mesenchymal stem cells

Adipose-derived mesenchymal stem cells (ADMSCs) are an ideal population for regenerative medical application. Both the isolation procedure and the culturing conditions are crucial steps, since low yield can limit further cell therapies, especially when minimal adipose tissue harvests are available for cell expansion. To date, a standardized procedure encompassing both isolation sites and expansion methods is missing, thus making the choice of the most appropriate conditions for the preparation of ADMSCs controversial, especially in view of the different applications needed. In this study, we compared the effects of three different commercial media (DMEM, aMEM, and EGM2), routinely used for ADMSCs expansion, and two supplements, FBS and human platelet lysate, recently proven to be an effective alternative to prevent xenogeneic antibody transfer and immune alloresponse in the host. Notably, all the conditions resulted in being safe for ADMSCs isolation and expansion with platelet lysate supplementation giving the highest isolation and proliferation rates, together with a commitment for osteogenic lineage. Then, we proved that the high ADMSC hematopoietic supportive potential is performed through a constant and abundant secretion of both GCSF and SCF. In conclusion, this study further expands the knowledge on ADMSCs, defining their identity definition and offers potential options for in vitro protocols for clinical production, especially related to HSC expansion without use of exogenous cytokines or genetic modifications

Extracellular Vesicle-Shuttled mRNA in Mesenchymal Stem Cell Communication

Mesenchymal stem cells (MSC) are multipotent cells able to differentiate into several cell types, hence providing cell reservoirs for therapeutic applications. The absence of detectable MSC homing at injury sites suggests that paracrine functions could, at least in part, be mediated by extracellular vesicles (EVs); EVs are newly identified players that are studied mainly as predictive or diagnostic biomarkers. Together with their clinical interests, EVs have recently come to the fore for their role in cell-to-cell communication. In this context, we investigated gene-based communication mechanisms in EVs generated by bone marrow and umbilical cord blood MSC (BMMSC and CBMSC, respectively). Both MSC types released vesicles with similar physical properties, although CBMSC were able to secrete EVs with faster kinetics. A pattern of preferentially incorporated EV transcripts was detected with respect to random internalization from the cytosol, after a validated normalization procedure was established. In the paradigm where EVs act as bioeffectors educating target cells, we demonstrated that kidney tubular cells lacking IL-10 expression and exposed to BMMSC-EVs and CBMSC-EVs acquired the IL-10 mRNA, which was efficiently translated into the corresponding protein. These findings suggest that horizontal mRNA transfer through EVs is a new mechanism in the MSC restoring ability observed in vivo that is here further demonstrated in an in vitro rescue model after acute cisplatin injury of tubular cells. Stem Cells 2017;35:1093\u20131105

How we make cell therapy in Italy

Tiziana Montemurro, Mariele Viganò, Silvia Budelli, Elisa Montelatici, Cristiana Lavazza, Luigi Marino, Valentina Parazzi, Lorenza Lazzari, Rosaria GiordanoCell Factory, Unit of Cell Therapy and Cryobiology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, ItalyAbstract: In the 21st century scenario, new therapeutic tools are needed to take up the social and medical challenge posed by the more and more frequent degenerative disorders and by the aging of population. The recent category of advanced therapy medicinal products has been created to comprise cellular, gene therapy, and tissue engineered products, as a new class of drugs. Their manufacture requires the same pharmaceutical framework as for conventional drugs and this means that industrial, large-scale manufacturing process has to be adapted to the peculiar characteristics of cell-containing products. Our hospital took up the challenge of this new path in the early 2000s; and herein we describe the approach we followed to set up a pharmaceutical-grade facility in a public hospital context, with the aim to share the solutions we found to make cell therapy compliant with the requirements for the production and the quality control of a high-standard medicinal product.Keywords: advanced therapy medicinal product, good manufacturing practices, stem cell

Dissection of the cord blood stromal component reveals predictive parameters for culture outcome

In regenerative medicine, human cord blood-derived multipotent mesenchymal stromal cells (CBMSCs) stand out for their biological peculiarities demonstrated in in vitro and in vivo preclinical studies. Here, we present our 9-year experience for the consistent isolation of CBMSCs. Although nearly one CB unit out of two retains the potential to give rise to MSC colonies, only 46% of them can be cultured till low passages (P 654), but one-fourth of those reaches even higher passages (P 658). Subsequent characterization for morphological, clonal, differentiation, and proliferation properties revealed two divergent CBMSC behaviors. In particular, a cumulative population doublings cut-off (CPD=15) was identified that undoubtedly distinguishes two growth curves, and different degrees of commitment toward osteogenesis were observed. These data clearly show the existence of at least two distinct CBMSC subsets: one mainly short-living and less proliferative (SL-CBMSCs), the other long-living, with higher growth rate, and, very importantly, with significantly (P 640.01) longer telomere (LL-CBMSCs). Moreover, significant differences in the immunoprofile before seeding were found among CB units giving rise to LL-CBMSCs or SL-CBMSCs or showing no colony formation. Finally, all the aforementioned results provided a peculiar and useful set of parameters potentially predictive for CBMSC culture outcome